- Is the Low-Thalidomide Dose MPT Regimen Beneficial?
-
Min CK
- KMID: 1729241
- Korean J Intern Med.
- 2011 Dec;26(4):400-402.
- doi: 10.3904/kjim.2011.26.4.400
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Visual Prognosis of Retinoblastoma in the Posterior Pole Treated with Primary Chemotherapy Plus Local Treatments
-
Kim JM, Kim JH, Kim SJ, Park KD, Shin HY, Ahn HS, Yu YS
- KMID: 1769088
- Korean J Ophthalmol.
- 2010 Dec;24(6):347-352.
- doi: 10.3341/kjo.2010.24.6.347
PURPOSE: To evaluate the visual outcomes of retinoblastoma in the posterior pole (RBPP) treated with chemotherapy plus local treatments and to address the prognostic factors that influence such outcomes. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution
-
Joo JD, Kim H, Kim YH, Han JH, Kim CY
- KMID: 2351109
- J Korean Med Sci.
- 2015 Nov;30(11):1597-1603.
- doi: 10.3346/jkms.2015.30.11.1597
This study was performed to validate the effectiveness and safety of concurrent chemoradiotherapy and adjuvant therapy with temozolomide for newly diagnosed glioblastoma multiforme as a standard treatment protocol. Between 2004... -
- CITED
-
- Close
- SHARE
-
- Close
- Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
-
Yang SH, Kim MK, Lee TK, Lee KS, Jeun SS, Park CK, Kang JK, Kim MC, Hong YK
- KMID: 2157831
- J Korean Med Sci.
- 2006 Aug;21(4):739-744.
- doi: 10.3346/jkms.2006.21.4.739
Numerous studies have demonstrated the clinical activity of temozolomide, a second-generation alkylating agent, against malignant brain tumors, however, its activity has not been reported in an Asian population. This study... -
- CITED
-
- Close
- SHARE
-
- Close
